Welcome! Thank you for subscribing to the Earnings360 newsletter, your daily source for quarterly earnings news and updates.
Each morning edition contains a wrap-up of today's pre-market earnings announcements and yesterday's earnings announcements after the closing bell.
Please take a moment to confirm your subscription below so we can ensure these updates reach your inbox.
Confirm Your Subscription Here
The Earnings360 Team
Tuesday's Featured Story 3 Up-and-Coming Stocks Showing Huge Momentum in Late 2025Written by Chris Markoch. Published 12/2/2025. Many investors have profited from the artificial intelligence (AI) trade in 2025, but several up-and-coming stocks in other sectors have also posted impressive gains this year. The three stocks in this article are still small caps; the largest market cap is just over $4 billion. However, they've made strong moves and underscore the idea that time in the market is often better than trying to time the market. Of course, if investors could see the future with absolute clarity, investing would be easy. The future is rarely clear, and a bullish outcome is not guaranteed. Still, the charts speak for themselves: investors who bought these stocks and had the patience to hold through rough patches are reaping the benefits today — and the stocks may not be done moving higher. Biotech Breakthrough: A Small Cap With a Big 2026 FDA Catalyst Some of Wall Street's biggest players have been taking advantage of the same early-morning price behavior for years — a pattern that appears shortly after the opening bell when overnight institutional flows hit the market. Most retail traders never notice it, but Dave Aquino has spent years studying this window and developed a simple routine built to capitalize on it without relying on news or predictions.
He calls it the Good Morning Cash Plan — a single morning setup designed to give traders a structured, rules-based approach before the day even begins. Dave breaks down the full method in a free training session, including how he identifies the setup each morning. Watch the Good Morning Cash Plan training here Key Points - These three up-and-coming stocks have delivered triple-digit gains in 2025 and continue to show strong momentum.
- Key catalysts—including clinical milestones, revenue acceleration, and consumer demand—suggest more upside ahead.
- Analysts remain bullish, with price targets indicating potential double-digit to triple-digit returns from current levels.
Celcuity Inc. (NASDAQ: CELC) is a clinical-stage biotechnology company that recently delivered positive clinical data for its first-in-class PI3K/mTOR inhibitor targeting HR+/HER2- metastatic breast cancer. The company's pivotal Phase 3 VIKTORIA trial is underway, and the company could potentially receive U.S. Food & Drug Administration (FDA) approval in 2026. Investors have been front-running those expectations, sending CELC stock up over 660%, with nearly all of those gains occurring since the end of July. At $99.30 as of this writing, the stock is within about 3% of its consensus price target. Meanwhile, Jefferies raised its price target on the stock to $134 from $108 on Dec. 2. The biggest risk is the cost of commercialization. In its most recent earnings report, Celcuity reported a strengthened balance sheet with $455 million in cash, cash equivalents and short-term investments — up about 72% year-over-year — and management believes that should be sufficient until commercialization begins. Fintech Disruptor Turning Revenue Growth Into Real Momentum At a time when traditional banks offer fewer appealing options, Dave Inc. (NASDAQ: DAVE) stands out. The Los Angeles-based fintech is best known for the Dave app. The app provides affordable, transparent financial tools that help users — many living paycheck to paycheck — avoid overdraft fees, budget more effectively and access short-term cash when needed. The company recently reported a 64% year-over-year increase in revenue and an 85% beat in adjusted earnings per share (EPS). DAVE stock is up 120% in 2025, and analysts see further upside. As of this writing the stock trades at $208.24, while the consensus price target is $304.25 — implying more than 46% upside. Some investors may be wary of the company's forward price-to-earnings (P/E) ratio of roughly 119x. However, analysts forecast earnings growth of over 117% in the next 12 months, which could justify that valuation if it materializes. Resale Retail Winner Riding a Massive Consumer Shift It's been another tough year for consumer staples stocks, but ThredUp Inc. (NASDAQ: TDUP) has been a notable exception. TDUP stock is up more than 430% in 2025, despite a sell-off of over 29% in the three months ending Dec. 1. The company operates an online consignment marketplace — well positioned as many consumers continue to stretch their budgets. The thrift and resale market was a $49 billion industry in 2024 and is expected to grow to $74 billion by 2029. TDUP is the smallest of the three names on this list, and short interest above 17% indicates active trader interest. Still, the company's Q3 earnings report showed strong year-over-year revenue growth, record new-buyer acquisition and a 37% YoY increase in orders. This could be a shorter-term trade, but ThredUp's core demographic — younger consumers — may remain budget-conscious for some time. Analysts' consensus price target of $12.50 implies about a 68% gain from its closing price on Dec. 1.
| 
